DNLI
Denali Therapeutics Inc. Common Stock
$20.99
-3.39%
-0.71
Notify me if price changes either direction
Buy DNLI stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
3.2B
Enterprise value
2.3B
Trailing PE
-7.8793774319066
Forward PE
-7.0786943
PEG Ratio
-0.45127343473647
Enterprise to EBITDA
-4.18
Price to book MRQ
3.3132818
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
EBITDA
-542073984
Diluted EPS TTM
-2.92
Total Cash (MRQ)
848.2M
Current ratio (MRQ)
9.791
Operating Cash Flow (TTM)
-397776992
DNLI trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
January 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
